Keyword

daprodustat

Description: A medication that inhibits hypoxia-inducible factor prolyl hydroxylase, used to stimulate red blood cell production in anemia associated with kidney disease.
Wikidata ID: wiki/Q27076986
OpenAlex ID: keywords/daprodustat
2021 · Ajay K. Singh, Kevin Carroll, et al. · New England Journal of Medicine · 274
2021 · Ajay K. Singh, Kevin Carroll, et al. · New England Journal of Medicine · 257
2019 · Neil S. Sanghani, Volker H. Haase · Advances in Chronic Kidney Disease · 195
2018 · Amy M Meadowcroft, Borut Cizman, et al. · Clinical Kidney Journal · 113
2017 · Jennifer L. Ariazi, Kevin J. Duffy, et al. · Journal of Pharmacology and Experimental Therapeutics · 98
2020 · Sohita Dhillon · Drugs · 92
2019 · Yoshiharu Tsubakihara, Tadao Akizawa, et al. · Therapeutic Apheresis and Dialysis · 49
2022 · Francesco Locatelli, Lucia Del Vecchio · Journal of the American Society of Nephrology · 44
2018 · Borut Cizman, Andy P. Sykes, et al. · Kidney International Reports · 41
2020 · Monica Mazzarino, Ilaria Perretti, et al. · Journal of Analytical Toxicology · 36
2022 · Armando Luis Negri · Clinical Kidney Journal · 35
2022 · Andrea Tóth, Dávid Máté Csiki, et al. · Frontiers in Pharmacology · 34
2016 · Holger Schmid, Wolfgang Jelkmann · Expert Opinion on Investigational Drugs · 34
Works count: 322
Citation count: 3,255
Year
Topic
Type